Inovio Pharmaceuticals, Inc. ( INO) - Key Metrics
INO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | ? | -$605.70 | -$535.96 | -$535.96 |
| 2025Q1 | $0 | -$725.11 | -$989.44 | -$989.44 |
INO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | 0.00 |
| 2025Q1 | ? | 0.00 |
INO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -1.80% | ? |
| 2025Q4 | -2.39% | ? |
| 2025Q3 | -17.73% | ? |
| 2025Q2 | -26.31% | ? |
| 2025Q1 | -60.84% | ? |
INO
Price: $1.12
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.58 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.8 million
Ebitda: -28.0 millionMarket Capitalization: 57.3 million